Sophoricoside Catalog No.:M24757-C po) treatment produces significant decreases

po) treatment produces significant decreases in hepatic expression of mRNAs for SREBP-1

selectively blocking the binding of the cofactor

714 displays inhibition of cholyl-lysyl fluorescein and taurocholate (TC) efflux into canaliculi in cryopreserved and fresh cultured human hepatocytes

InChiKey: YRXOQXUDKDCXME-YIVRLKKSSA-N

OSU-03012 remarkably decreases expression of EGFR protein in the tumors by 48% compared with vehicle controls and also prevents YB-1 from binding to the EGFR promoter in MDA-MB-435/LCC6 xenografts

Sophoricoside Catalog No.:M24757-C po) treatment produces significant decreasesSophoricoside is an isoflavone glycoside isolated from Sophora japonica and has anti inflammatory, anti cancer and immunosuppressive effects. Product information CAS Number: 152 95 4 Molecular Weight: 432. 38 Formula: C21H20O10 Chemical Name: 5,7 dihydroxy 3 (4 {[(2S,3R,4S,5S,6R) 3,4,5 trihydroxy 6 (hydroxymethyl)oxan 2 yl]oxy}phenyl) 4H chromen 4 one Smiles: OC[C@H]1O[C@@H](OC2C=CC(=CC=2)C2=COC3=CC(O)=CC(O)=C3C2=O)[C@H](O)[C@@H](O)[C@@H]1O InChiKey: